Predictive ability of level A in vitro-in vivo correlation for ringcap controlled-release acetaminophen tablets
J T Dalton1, A B Straughn, D A Dickason
1Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus 43210, USA. dalton.1@osu.edu
Pharmaceutical Research
|January 12, 2002
Summary
This study establishes a strong in vitro-in vivo correlation (IVIVC) for acetaminophen sustained-release tablets. In vitro dissolution accurately predicts in vivo drug absorption, supporting its use for formulation development.
Area of Science:
- Pharmacokinetics and Drug Delivery
- Pharmaceutical Sciences
- Biopharmaceutics
Background:
- Sustained-release formulations aim to provide controlled drug release over time.
- Establishing an in vitro-in vivo correlation (IVIVC) is crucial for predicting drug performance and reducing clinical testing.
- Acetaminophen is a widely used analgesic and antipyretic, often formulated in various dosage forms.
Purpose of the Study:
- To establish and validate an in vitro-in vivo correlation (IVIVC) for two acetaminophen (750 mg) sustained-release formulations: a matrix tablet and a RingCap banded matrix tablet.
- To assess the predictability of in vitro dissolution data for in vivo drug absorption and disposition.
Main Methods:
- In vitro dissolution testing using a USP type III apparatus.
- In vivo disposition studies in a three-way crossover design with an immediate-release acetaminophen formulation.
- Development of an IVIVC model using mean fraction dissolved (FD) and mean fraction absorbed (FA).
- Internal and external validation of the IVIVC model by simulating plasma concentration-time profiles.
Main Results:
- A statistically significant and strong relationship (r² = 0.997, P < 0.001) was found between FD and FA for the matrix tablet.
- The established IVIVC model accurately predicted plasma concentration-time profiles for both sustained-release formulations, with prediction errors for CMAX and AUCL below 10%.
- The results demonstrate the internal and external predictability of the developed IVIVC.
Conclusions:
- In vitro dissolution data serve as reliable predictors of in vivo acetaminophen absorption.
- The findings support the broader application of in vitro dissolution data for readily soluble and absorbed drugs.
- Acetaminophen can be considered a suitable model drug for evaluating novel sustained-release systems.
- The study highlights current limitations in predicting and validating IVIVC.
Related Concept Videos
01:14Time Course of Drug Effect
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
01:15Drug Concentration Versus Time Correlation
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:10In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
01:20Drug Product Performance: In Vitro–In Vivo Correlation
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while adhering...
01:30Modified-Release Drug Delivery Systems: Bioavailability
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...